Newsletter | January 6, 2026
FEATURED EDITORIAL
To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
By Victor Lien
The choice of delivery dictates the complexity of manufacturing, which in turn determines the eventual cost and accessibility of the therapy.
MOST POPULAR NEWS
•
New Blood Test Matches Breast Cancer Patients To The Right Treatment Without A Biopsy
ALZpath And Siemens Healthineers Work To Advance Blood-Based Alzheimer's IVD Testing
Co-Diagnostics Receives Australian Patent Covering Co-Dx PCR Platform Technologies
Leica Biosystems Expands Clinical Digital Pathology Portfolio At DPAI 2025
VANUDIS Replaces Fragmented Manual Lab Processes With Cenevo Labguru Solution
Diasorin Receives FDA 510(K) Clearance And CLIA-Waiver For 4- Plex Respiratory Panel
KDA Group To Integrate New Clinical Alerts Into Medherize Platform
Aces Diagnostics Announces Development Partnerships For Novel LymeSeek Test
Beckman Coulter Life Sciences Introduces The Biomek i3 Benchtop Liquid Handler
Roche Expands Automated Mass Spectrometry With Antibiotics Drug Monitoring CE Mark Approval
WORK Medical Subsidiary Obtains Manufacturing Approval For AI-Automated Blood Cell Morphology Analyzer
